-
[1]
Song Hu, Fahu Yuan, Lingyan Feng, Fang Zheng, Feili Gong, Hanju Huang, Binlian Sun, 2018: KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China, Virologica Sinica, 33, 369-372. doi: 10.1007/s12250-018-0042-1
-
[2]
熊开钧, 王心禾, 金慰鄂, 黄华芳, 姚梦林, 曾令兰, 韩才英, 范红梅, 吴章琦, 孙继山, 1986: EFFECT OF SMALL DOSAGE OF INTERFERON ON VIRAL MARKERS OF CHRONIC HEPATITIS B, Virologica Sinica, 1, 9-.
-
[3]
黄华芳, 熊开钧, 何生松, 李瑗, 王萍, 蔡淑清, 曾令兰, 王心禾, 1991: The Observation on the Antiviral Effect of Ribavirin and Combining with Interferon in Patients with Chronic Hepatitis B, Virologica Sinica, 6, 201-.
-
[4]
熊开钧, 黄华芳, 金慰鄂, 姚梦林, 曾令兰, 贺永文, 何生松, 吴章琦, 1986: THE INFLUENCE OF SMALL DOSAGES OF INTERFERON ON VIRUSES ON DIFFERENT STAGES OF CHRONIC HEPATITIS B, Virologica Sinica, 1, 24-.
-
[5]
Huan Li, Ren Wang, Ze Yu, Run Shi, Jie Zhang, Shanshan Gao, Ming Shao, Shuzhong Cui, Zhenxing Gao, Jiang Xu, Man-Sun Sy, Chaoyang Li, 2021: Tumor Necrosis Factor α Reduces SNAP29 Dependent Autolysosome Formation to Increase Prion Protein Level and Promote Tumor Cell Migration, Virologica Sinica, 36, 458-475. doi: 10.1007/s12250-020-00320-4
-
[6]
彭光勇, 姚堃, 任强, 季晓辉, 1999: Human Herpesvirus 7 Induces Tumor Necrosis Factor Alpha in Umbilical Cord Blood M ononuclear Cell Cultures, Virologica Sinica, 14, 328-332.
-
[7]
黄友华, 孙伟, 张奇亚*, 2005: Analysis and Expression of Tumor Necrosis Factor Receptor Homolog from LCDV-C, Virologica Sinica, 20, 652-655.
-
[8]
黄华芳, 熊开钧, 王心禾, 金慰鄂, 曾令兰, 吴章琦, 1987: THE FOLLOWED-UP OBSERVATION OF ANTIVIRAL TREATMENT WITH SMALL DOSE INTERFERON IN CHRONIC HEPATITIS B, Virologica Sinica, 2, 34-.
-
[9]
黄华芳, 熊开钧, 王心禾, 曾令兰, 刘彼息, 曾凡珍, 吴章琦, 1990: Followed-up Observation on Antiviral Effect of Combined Treatment of Small Dosage of Interferon and Thymosin in Patients with Chronic Hepatitis B, Virologica Sinica, 5, 69-.
-
[10]
赵文彬, 黄浦昌, 王行钵, 吴桃林, 周克捷, 张秀惠, 张元英, 林克泳, 1990: Efficacy of Treating Chronic Hepatitis B with HB Vaccine and Small Doses of Interferon and Thymosin, Virologica Sinica, 5, 379-.
-
[11]
雷周云, 张玲霞, 蒋性凡, 欧阳琼莲, 陆江春, 李安信, 1991: The Clinical Investigation of the Combined Treatment of Interferon and Chinese drugs on Patients with Chronic Active Hepatitis B, Virologica Sinica, 6, 107-.
-
[12]
黄华芳, 熊开钧, 王心禾, 曾令兰, 李嫒, 贺永文, 杨泽川, 凌美霞, 范家珍, 吴章琦, 1989: The Contrast Observation of Antiviral Effect of Interferon with Two Different Dosages in Chronic Hepatitis B, Virologica Sinica, 4, 383-.
-
[13]
黄华芳, 熊开钧, 曾令兰, 何生松, 杨泽川, 1994: Observation on the Antiviral Effect of HBIG .Acyclovir and Interferon Combining Treatment in Chronic Hepatitis B, Virologica Sinica, 9, 304-.
-
[14]
Minghui Li, Lu Zhang, Yao Lu, Qiqi Chen, Huihui Lu, Fangfang Sun, Zhan Zeng, Gang Wan, Linqing Zhao, Yao Xie, 2021: Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a, Virologica Sinica, 36, 311-320. doi: 10.1007/s12250-020-00290-7
-
[15]
Minghui Li, Fangfang Sun, Xiaoyue Bi, Yanjie Lin, Liu Yang, Yao Lu, Lu Zhang, Gang Wan, Wei Yi, Linqing Zhao, Yao Xie, 2022: Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients, Virologica Sinica, 37, 390-397. doi: 10.1016/j.virs.2022.03.001
-
[16]
熊开钧, 黄华芳, 王心禾, 金慰鄂, 曾令兰, 杨泽川, 凌美霞, 张雪珍, 吴章琦, 1987: THE TREATMENT EFFECT OF HEPATITIS B WITH INTERFERON AND ACYCLOVIR, Virologica Sinica, 2, 17-.
-
[17]
曹志惠, 陈慎宝, 丁如宁, 周瑶玺, 1991: Inhibitory Effect of HSV Infection in Vitro on IgG and Effect of TNF and r-IFN on It, Virologica Sinica, 6, 183-.
-
[18]
饶敏, 张淑玲, 董继华, 李淑莉, 2006: Inhibition of Hepatitis B Virus Replication by Homoharringtonine, IFN-α1b, Hydroxycamptothecin and Norfloxacin, Virologica Sinica, 21, 284-287.
-
[19]
余晖, 未久仙, 熊开钧, 吴章琦, 1986: A PRELIMINARY REVIEW OF TREATING HEPATITIS B BY USING SMALL DOSAGE INTERFERON, Virologica Sinica, 1, 55-.
-
[20]
You-hua XIE, Ran HONG, Wei LIU, Jing LIU, Jian-wei ZHAI, 2010: Development of Novel Therapeutics for Chronic Hepatitis B*, Virologica Sinica, 25, 294-300. doi: 10.1007/s12250-010-3138-9